|Articles|February 19, 2016

EUPATI Launches Educational Toolbox on Medicines Research & Development

Author(s)DIA

EUPATI Launches Educational Toolbox on Medicines Research & Development

Open up and explore the European Patients’ Academy’s (EUPATI’s) new online Toolbox on Medicines Research & Development, available to European patient groups, patient advocates, and anyone who is interested in learning more about the medicines R&D process. “Our vision is that thousands of patient advocates in Europe will leverage the toolbox to enable more meaningful patient involvement and partnership in medicines R&D,” says EUPATI Director Jan Geissler.


Related to this article

Pharmaceutical Executive Daily
The FDA approves Roche’s Tecentriq for a subset of colon cancer patients, TRexBio and Retension Pharmaceuticals price new IPOs, and a Pharmaceutical Executive feature examines what it takes to turn precision medicine’s biological gains into deliverable therapies.
Naoki Okamura: Post-Patent Plan and Purpose
Astellas CEO Naoki Okamura is putting a “patient axis” operating model, a broader portfolio of strategic brands and a new generation of science to work in the company’s bid to return to record growth.